Recipharm invests in Brexit preparations
Recipharm, the contract development and manufacturing organisation (CDMO), has established a dedicated taskforce to manage the potential impact of Brexit on its organisation. With less than a year until the UK exits the European Union (EU), the Sweden headquartered global CDMO is focused on managing the transition with minimal impact to its operations and customers. The formation of the ‘Brexit taskforce’ will see Recipharm prioritise its preparations and invest in the necessary capabilities and equipment within its UK and European facilities to ensure seamless operations post March